Simple advice on lifestyle habits and long-term changes in biomarkers of inflammation and vascular adhesion in healthy middle-aged men

European Journal of Clinical Nutrition

Volumn 64, Issue 12, 2010, Pages 1450-1456

  Sjogren P ^a   Cederholm, T ^a   Heimburger M ^b   Stenvinkel, P ^c   Vedin, I ^d   Palmblad, J ^d   Hellenius, M L ^e  

^a UPPSALA UNIVERSITY   (Sweden)

^b Department of Rheumatology ^*  (Sweden)

^c Division of Occupational Medicine   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

atherosclerosis; diet exercise; inflammation; prevention; vascular adhesion

Indexed keywords

APOLIPOPROTEIN B; C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CALORIC INTAKE; CARBOHYDRATE INTAKE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; EATING HABIT; EXERCISE; FAT INTAKE; HUMAN; HYPERCHOLESTEROLEMIA; INFLAMMATION; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; PATIENT COUNSELING; PHYSICAL ACTIVITY; PREDICTION; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; TREATMENT OUTCOME;

ADULT; APOLIPOPROTEINS B; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; E-SELECTIN; FOOD HABITS; HUMANS; HYPERCHOLESTEROLEMIA; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; INTERVENTION STUDIES; LIFE STYLE; MALE; MEN'S HEALTH; MIDDLE AGED; VASCULAR CELL ADHESION MOLECULE-1;

EID: 78649720721     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2010.182     Document Type: Article

References (37)

1. Akdim F, van Leuven SI, Kastelein JJ, Stroes ES (2007). Pleiotropic effects of statins: stabilization of the vulnerable atherosclerotic plaque? Curr Pharm Des 13, 1003-1012.
2. Alberti KG, Gries FA (1988). Management of non-insulin-dependent diabetes mellitus in Europe: a concensus view. Diabet Med 5, 275-281.
3. Basu A, Devaraj S, Jialal I (2006). Dietary factors that promote or retard inflammation. Arterioscler Thromb Vasc Biol 26, 995-1001.
4. Carlson K (1973). Lipoprotein fractionation. J Clin Pathol Suppl 5, 32-37.
5. Deanfield JE, Halcox JP, Rabelink TJ (2007). Endothelial function and dysfunction: testing and clinical relevance. Circulation 115, 1285-1295.
6. Dvorakova-Lorenzova A, Suchanek P, Havel PJ, Stavek P, Karasova L, Valenta Z et al. (2006). The decrease in C-reactive protein concentration after diet and physical activity induced weight reduction is associated with changes in plasma lipids, but not interleukin-6 or adiponectin. Metabolism 55, 359-365.
7. EAS (1987). Strategies for the prevention of coronary heart disease: a policy statement of the European Atherosclerosis Society. Eur Heart J 8, 77-88.
8. Fornoni A, Raij L (2005). Metabolic syndrome and endothelial dysfunction. Curr Hypertens Rep 7, 88-95.
9. Fung TT, McCullough ML, Newby PK, Manson JE, Meigs JB, Rifai N et al. (2005). Diet-quality scores and plasma concentrations of markers of inflammation and endothelial dysfunction. Am J Clin Nutr 82, 163-173. (Pubitemid 41716389)
10. Galisteo M, Duarte J, Zarzuelo A (2008). Effects of dietary fibers on disturbances clustered in the metabolic syndrome. J Nutr Biochem 19, 71-84.
11. Giugliano D, Ceriello A, Esposito K (2006). The effects of diet on inflammation: emphasis on the metabolic syndrome. J Am Coll Cardiol 48, 677-685. (Pubitemid 44175717)
12. Gordon NF, Scott CB (1991). The role of exercise in the primary and secondary prevention of coronary artery disease. Clin Sports Med 10, 87-103.
13. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R et al. (2007). European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Eur Heart J 28, 2375-2414.
14. Hellenius ML, Brismar KE, Berglund BH, de Faire UH (1995a). Effects on glucose tolerance, insulin secretion, insulin-like growth factor 1 and its binding protein, IGFBP-1, in a randomized controlled diet and exercise study in healthy, middle-aged men. J Intern Med 238, 121-130.
15. Hellenius ML, Dahlof C, Aberg H, Krakau I, de Faire U (1995b). Quality of life is not negatively affected by diet and exercise intervention in healthy men with cardiovascular risk factors. Qual Life Res 4, 13-20.
16. Hellenius ML, de Faire U, Berglund B, Hamsten A, Krakau I (1993). Diet and exercise are equally effective in reducing risk for cardiovascular disease. Results of a randomized controlled study in men with slightly to moderately raised cardiovascular risk factors. Atherosclerosis 103, 81-91.
17. Hellenius ML, de Faire U, Kallner A, Hamsten A, Krakau I (1994). Effects of diet and exercise on apolipoproteins and lipoprotein(a): results of a randomized controlled study in men. Nutr Metab Cardiovasc Dis 4, 142-147.
18. Hellenius ML, Krakau I, De Faire U (1997). Favourable long-term effects from advice on diet and exercise given to healthy men with raised cardiovascular risk factors. Nutr Metab Cardiovasc Dis 7, 293-300.
19. Hwang SJ, Ballantyne CM, Sharrett AR, Smith LC, Davis CE, Gotto Jr AM et al. (1997). Circulating adhesion molecules VCAM-1, ICAM-1 and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation 96, 4219-4225.
20. Ishikawa S, Kayaba K, Gotoh T, Nakamura Y, Kario K, Ito Y et al. (2007). Comparison of C-reactive protein levels between serum and plasma samples on long-term frozen storage after a 13.8 year interval: the JMS Cohort Study. J Epidemiolog 17, 120-124.
21. Jenkins DJ, Kendall CW, Marchie A, Faulkner DA, Wong JM, de Souza R et al. (2003). Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein. JAMA 290, 502-510.
22. Kenis G, Teunissen C, De Jongh R, Bosmans E, Steinbusch H, Maes M (2002). Stability of interleukin 6, soluble interleukin 6 receptor, interleukin 10 and CC16 in human serum. Cytokine 19, 228-235.
23. Kim JA, Montagnani M, Koh KK, Quon MJ (2006). Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 113, 1888-1904.
24. Kontogianni MD, Zampelas A, Tsigos C (2006). Nutrition and inflammatory load. Ann NY Acad Sci 1083, 214-238.
25. Kuvin JT, Karas RH (2003). Clinical utility of endothelial function testing: ready for prime time? Circulation 107, 3243-3247.
26. Lanas F, Avezum A, Bautista LE, Diaz R, Luna M, Islam S et al. (2007). Risk factors for acute myocardial infarction in Latin America: the INTERHEART Latin American study. Circulation 115, 1067-1074.
27. Libby P (2002). Inflammation in atherosclerosis. Nature 420, 868-874.
28. Libby P, Ridker PM, Maseri A (2002). Inflammation and atherosclerosis. Circulation 105, 1135-1143.
29. Lopez-Garcia E, Schulze MB, Fung TT, Meigs JB, Rifai N, Manson JE et al. (2004). Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction. Am J Clin Nutr 80, 1029-1035.
30. Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J (1998). Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 351, 88-92.
31. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR (2002). Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347, 1557-1565.
32. Riserus U, De Faire U, Berglund L, Hellenius ML (2010). Sagittal abdominal diameter as a screening tool in clinical research: cutoffs for cardiometabolic risk. J Obesity, e-pub ahead of print 11 March 2010, doi: 10.1155/2010/757939.
33. Ross R (1993). The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362, 801-809.
34. Schram MT, Stehouwer CD (2005). Endothelial dysfunction, cellular adhesion molecules and the metabolic syndrome. Horm Metab Res 37 (Suppl 1), 49-55.
35. Sjogren P, Basta G, de Caterina R, Rosell M, Basu S, Silveira A et al. (2007). Markers of endothelial activity are related to components of the metabolic syndrome, but not to circulating concentrations of the advanced glycation end-product N epsilon-carboxymethyl-lysine in healthy Swedish men. Atherosclerosis 195, e168-e175.
36. Tzoulaki I, Murray GD, Lee AJ, Rumley A, Lowe GD, Fowkes FG (2005). C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study. Circulation 112, 976-983.
37. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F et al. (2004). Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364, 937-952.